-transparent.png){kind=logo}
1,1,1- and 1,1,2-trichloroethane and 1,1,2,3-tetrachloroethane stimulate CO- inhibitable NADPH oxidation by hepatic microsomes. Incubation of the chloroethanes, hepatic microsomes, an NADPH-generating system and EDTA results in the production of chlorinated metabolites. Both NADPH oxidation and metabolite production are inhibited by CO, SKF 525A and/or metyrapone The induction of cytochrome P-450 with phenobarbital enhances the binding and metabolism of the chloroalkanes, while the induction of cytochrome P-448 with beta-naphthoflavone does not. 1,1,1-trichloroethane is converted to 2,2,2-trichloroethanol by hepatic microsomal cytochrome P-450, while the major metabolites of 1,1,2-trichloroethane and 1,1,2,2-tetrachloroethane from this enzyme system are mono- and dichloroacetate, respectively. Mechanisms for the production of these metabolites are suggested. The relative mutagenic and carcinogenic potentials of the three chloroethanes are considered with respect to their relative extents of metabolism and their proposed metabolic pathways.
K M Ivanetich, and
L H Van den Honert
May 1984,
Carcinogenesis,
K M Ivanetich, and
L H Van den Honert
June 1982,
Biochemical pharmacology,
K M Ivanetich, and
L H Van den Honert
January 1989,
Drug metabolism reviews,
K M Ivanetich, and
L H Van den Honert
June 1982,
Biochemical pharmacology,
K M Ivanetich, and
L H Van den Honert
July 1983,
Biochemical and biophysical research communications,
K M Ivanetich, and
L H Van den Honert
March 1981,
Biochemical pharmacology,
K M Ivanetich, and
L H Van den Honert
March 1980,
Biochemical pharmacology,
K M Ivanetich, and
L H Van den Honert
October 1980,
Biochemical pharmacology,
K M Ivanetich, and
L H Van den Honert
August 1984,
Biochemical and biophysical research communications,
K M Ivanetich, and
L H Van den Honert
November 1997,
European journal of biochemistry,
